October 24, 2023
A New York federal judge has granted final approval to a $3 million deal that ends an investor suit accusing a cannabis and tobacco engineering company of concealing a U.S. Securities and Exchange Commission investigation.
October 18, 2023
A New York magistrate judge has recommended final approval for a $3 million settlement in investors' lawsuit alleging that a cannabis and tobacco engineering company concealed a U.S. Securities and Exchange Commission investigation, along with a $1 million payout to the investors' attorneys.
August 30, 2023
Attorneys have asked a New York federal judge to award them $1 million in legal fees for representing a group of investors who accused a cannabis and tobacco engineering company of concealing a U.S. Securities and Exchange Commission inquiry about its accounting controls.
July 03, 2023
A New York federal judge has greenlighted a $3 million settlement in a class action in which investors accused cannabis and tobacco engineering company 22nd Century Group of concealing a U.S. Securities and Exchange Commission inquiry of its accounting controls, leading to a stock drop when it came to light.
June 16, 2023
A New York magistrate judge has recommended preliminary approval of a class settlement with investors who accused cannabis and tobacco engineering company 22nd Century Group of concealing a U.S. Securities and Exchange Commission inquiry of its accounting controls, leading to a stock drop when it came to light.
April 26, 2023
Cannabis and tobacco engineering company 22nd Century Group has reached a $3 million settlement deal with investors who claim the company concealed a U.S. Securities and Exchange Commission probe of the company's accounting controls.
January 06, 2023
A New York federal judge on Friday refused to let a cannabis and tobacco engineering company escape claims that it hid a U.S. Securities and Exchange Commission investigation, finding that investors have sufficiently alleged that the company had motive and opportunity to avoid disclosing the matter, and later made statements it knew was false.
September 26, 2022
Investors are pushing back against a hemp biotech company's bid to dismiss a proposed class action alleging its cover-up of a U.S. Securities and Exchange Commission investigation caused stock to drop, arguing the complaint shows the company and its officers knew about the investigation and deliberately hid it to inflate stock prices.
August 09, 2022
A company working to bioengineer tobacco and cannabis is asking a New York federal court to toss the last remaining claims in an investor group's stock-drop suit, saying the complaint still relies on claims left dismissed by the Second Circuit and fails to show any motive for allegedly hiding the existence of a U.S. Securities and Exchange Commission investigation.
January 19, 2021
A New York federal judge has tossed a proposed investor class action accusing a tobacco and hemp biotechnology company of hiding a U.S. Securities and Exchange Commission investigation into its accounting problems, finding that the company had already told investors about the underlying issues.